Osvaldo L. Cerda
B, Argentina
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Impact of Methotrexate Discontinuation on the Immunogenicity of COVID-19 Vaccines in Patients With Rheumatoid Arthritis.
Journal: Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases
Published: November 11, 2024
Modifications on lipid profile and high-density lipoprotein function related to treatment with tofacitinib in female patients with rheumatoid arthritis: Impact of previous therapy with biological agents.
Journal: Journal of clinical lipidology
Published: July 09, 2024
Humoral and T Cell Response to SARS-CoV-2 Vaccination in Patients With Rheumatoid Arthritis.
Journal: Arthritis care & research
Published: February 08, 2023
Immune Response to SARS-CoV-2 Third Vaccine in Patients With Rheumatoid Arthritis Who Had No Seroconversion After Primary 2-Dose Regimen With Inactivated or Vector-Based Vaccines.
Journal: The Journal of rheumatology
Published: July 26, 2022
Effect of Tocilizumab on LDL and HDL Characteristics in Patients with Rheumatoid Arthritis. An Observational Study.
Journal: Rheumatology and therapy
Published: February 02, 2021
Adherence to treatment with tofacitinib in patients with rheumatoid arthritis in daily clinical practice.
Journal: Reumatologia clinica
Published: June 17, 2020
Changing rate of serious infections in biologic-exposed rheumatoid arthritis patients. Data from South American registries BIOBADABRASIL and BIOBADASAR.
Journal: Clinical rheumatology
Published: January 06, 2019
Tuberculin test conversion in patients with chronic inflammatory arthritis receiving biological therapy.
Journal: European journal of rheumatology
Published: June 22, 2018
Showing 1-9 of 9
Last Updated: 09/26/2026